SAGE THERAPEUTICS INC shareholders Q2 2023

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 224 filers reported holding SAGE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.

SAGE THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
FRANKLIN RESOURCES INC 301,674$14,184,7110.01%
STATE OF WISCONSIN INVESTMENT BOARD 49,386$2,322,1300.01%
PRICE T ROWE ASSOCIATES INC /MD/ 1,080,153$50,7890.01%
METROPOLITAN LIFE INSURANCE CO/NY 2,891$135,9350.01%
HRT FINANCIAL LP 16,892$7940.01%
AMERICAN INTERNATIONAL GROUP, INC. 25,447$1,196,5180.01%
VANGUARD GROUP INC 5,032,437$236,625,1880.01%
Arizona State Retirement System 15,096$709,8140.01%
STATE STREET CORP 2,299,140$108,105,5630.01%
NORTHERN TRUST CORP 635,303$29,871,9470.01%
SG Americas Securities, LLC 16,760$7880.01%
GEODE CAPITAL MANAGEMENT, LLC 1,067,545$50,195,9810.01%
BlackRock Inc. 4,424,206$208,026,1670.01%
Nuveen Asset Management, LLC 313,449$14,738,3720.01%
Cubist Systematic Strategies, LLC 16,071$755,6580.01%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 391,168$18,392,7190.01%
GOLDMAN SACHS GROUP INC 511,965$24,072,5940.01%
Tower Research Capital LLC (TRC) 2,902$136,4520.01%
Assenagon Asset Management S.A. 32,605$1,533,0870.01%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 85,073$4,0000.01%
External links

This page lists SAGE THERAPEUTICS INC's shareholders in Q2 2023. To view SAGE THERAPEUTICS INC's shareholder history, click here.